Patients are being recruited for a trial to determine whether chemicals in cannabis can slow the impact of multiple sclerosis. Evidence suggests the drug may relieve symptoms but the three-year national trial is also to determine whether it slows the disease’s...
The use of cannabis is common among patients with inflammatory bowel disease (IBD), according to survey data to be published in the European Journal of Gastroenterology and Hepatology. An international team of researchers from Mount Sinai Hospital in Toronto and the...
